Latest Developments and Insights

The U.S.-China Trade War and Its Impacts on Investigational Drug Supply Chains
The ongoing U.S.-China trade war, now entering its seventh year, has evolved beyond tariffs into a broader strategic contest over technology, industrial policy, and national security. For the pharmaceutical sector — particularly the supply chains evolved to manufacture investigational drugs…
Read Full Article

Women’s History Month 2025
Sujata Kulkarni Why did you choose a career in biopharma? Growing up, I didn’t have the option to pursue medicine due to various reasons, so I had to select a field that aligned with my interests. This is when my…
Read Full Article

CFD Applications in Design of Manufacturing Processes and Facilities
Developing the manufacturing process can be one of the most time- and resource-intensive aspects of pharmaceutical development. Staying competitive requires leveraging cutting-edge tools that enhance efficiency, reduce costs, and improve overall process performance. One such tool is Computational Fluid Dynamics…
Read Full Article

Accelerating Cancer Treatment Approvals: The FDA’s Real-Time Oncology Review (RTOR) Program
In the ever-evolving landscape of cancer treatment, timely access to effective therapies is crucial. The FDA’s Real-Time Oncology Review (RTOR) program is a groundbreaking initiative designed to expedite the review process for oncology drugs and biologics ensuring that patients receive…
Read Full Article

The Evolution of US Biologic Drug Regulations
In the first instalment of our multi-part series, the key differences between biologic drugs and traditional small molecule drugs such as active pharmaceutical ingredient source, molecular size, structural complexity and immunogenicity were introduced. In this second instalment, we explore the…
Read Full Article

Navigating the Evolution from ICH Q2(R1) to ICH Q2(R2) and Implementation of ICH Q14 in Biopharmaceutical Method Validation
In the dynamic landscape of biopharmaceutical development, adherence to evolving international standards is crucial. The recent updates from International Council for Harmonisation (ICH) Q2 “Validation of Analytical Procedures” from Revision 1 to Revision 2, coupled with the introduction of ICH…